Circulating catecholamines and metabolic effects of captopril in NIDDM patients

Diabetes Care

Volumn 19, Issue 3, 1996, Pages 226-230

  De Mattia, Giancarlo ^a   Ferri, Claudio ^a   Laurenti, Oriana ^a   Cassone Faldetta, Maria ^a   Piccoli, Alfonso ^a   Santucci, Anna ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; ANGIOTENSIN; CAPTOPRIL; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MONOCOMPONENT INSULIN; NORADRENALIN; RENIN;

ADULT; ARTICLE; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; GLUCOSE UTILIZATION; HUMAN; INSULIN INFUSION; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; RANDOMIZED CONTROLLED TRIAL;

EID: 0030027910     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.3.226     Document Type: Article

References (39)

1. Gavras H, Gavras I: Angiotensin convening enzyme inhibitors: properties and side effects. Hypertension 11 (Suppl. II):1137-1141, 1988
2. Rett K, Jauch KW, Wicklmayr M, Dietze G, Fink E, Mehnert H: Angiotensin convening enzyme inhibitors in diabetes: experimental and human experience. Postgrad Med J 62 (Suppl. I):59-64, 1986
3. Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G: Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 17: 448-454, 1987
4. Ferri C, Bellini C, Laurenti O, Cassone-Faldetta M, Santucci A, De Mattia G: Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in non-insulin-dependent diabetic patients. Diabetes Care 18:226-233, 1995
5. Alkharouf J, Corry D, Tuck M: Long-term effects of the angiotensin convening enzyme inhibitor captopril on metabolic control in non-insulin-depependent diabetes mellitus. Am J Hypertens 6:337-343, 1993
6. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkubo Y, Miyamura N, Miyata T, Yano T, Schichiri M: Effect of insulin sensitivity of converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans Diabetologia 37:300-307, 1994
7. Berne C, Pollare T, Lithell H: Effects of antihypertensive treatment on insulin sensitivity with special regard to ACE inhibitors Diabetes Care 14 (Suppl. 4): 39-47, 1991
8. Laakso M, Edelman SV, Brechtel G, Baron AD: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man, a novel mechanism for insulin resistance. J Clin Invest 85:1844-1852, 1990
9. Kodama J, Katayama S, Tanaka K, Itabashi A, Kawazu S, Ishii J: Effects of captopril on glucose concentrations: possible role of augmented postprandial forearm blood flow. Diabetes Care 13:1109-1113, 1990
10. Falcon JP, Philips MI, Hoffman WE, Brody MJ: Effects of intraventricular angiotensin II mediated by sympathetic nervous system. Am J Physiol 235:H392-H399, 1978
11. Cleland IGF, Semple PF, Hodsman GP, Ball SG, Ford I, Dargie HJ: Angiotensin II levels, haemodynamic and sympathoadrenal function after low dose captopril in heart failure. Am J Med 77.880-886, 1984
12. Zimmerman BG: Actions of angiotensin on adrenergic nerve endings. Fed Proc 37: 199-202, 1978
13. Zimmerman BG: Blockade of adrenergic potentiating effects of angiotensin by 1-sar,8-ala angiotensin. J Pharmacol Exp Ther 183:486-492, 1973
14. Khairallah DA: Action of angiotensin in adrenergic nerve endings inhibition of norepinephrine uptake. Fed Proc 31: 1351-1357, 1972
15. Feldeberg W, Lewis GP: The action of peptides on the adrenal medulla: release of adrenaline by bradykinin and angiotensin. J Physiol 171:98-108, 1964
16. Garber AJ, Cryere PE, Raymond MW, Paghara AS, Kippenis D: The role of adrenergic mechanisms m the substrate and hormonal response to insulin induced hypoglycemia in man. J Clin Invest 58:7-15, 1976
17. Folkow B, Di Bona GF, Hjendahl P, Thören PH, Wallin BG: Measurements of plasma norepinephrine concentrations in human primary hypertension: a word of caution on their applicability for assessing neurogenic contribution Hypertension 5:399-403, 1993
18. Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ: Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 5:552-559, 1983
19. Uehlinger DE, Ferrier CP, Matthieu R, Reuter K, Gnaedinger MP, Saxenhofer H, Shaw S, Weidmann P. Anti-hypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition. J Hypertens 7:901-907, 1989
20. Strocchi E, Malini PL, Ciavarella A, Valtancoli G, Ricci C, Mustacchio A. Vannini P, Ambrosiom E: ACE inhibition in diabetic patients: effect on pressor responsiveness to noradrenaline J Hum Hypertens 6:317-319, 1992
21. Ciavarella A, Mustacchio A, Ricci C, Capelli M, Vanmni P: Enhanced pressor responsiveness to norepinephrine in type II diabetes Diabetes Care 12 1484-1487, 1994
22. Ewing DJ, Martyn CN, Young RJ, Clark BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes Diabetes Care 8 491-498, 1985
23. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
24. Dimsdale JE, Moss J: Plasma catecholamines in stress and exercise. JAMA 243: 340-342, 1980
25. Santoro D, Natali A, Palombo C, Brandi LS, Piatti M, Ghione S, Ferrannini E. Effects of chronic angiotensin convening enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension 20:181-191, 1992
26. Ferri C, Bellini C, Baldoncini R, Leonetti Luparini R, Perrone A, Santucci A: Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients. Circulation 90:2859-2869, 1994
27. Mauricio-Leguizamo G, Heineman L, Scharf RE, Berger M: Effect of 8 hours of hyperinsulinaemia on haemostatic parameters in healthy man. Diabetologia 32: 606-610, 1989
28. Schwartz NA, Clutter WE, Cryer PE: Glycemic threshold for activation of glucose counterregulatory systems are higher than the thresholds for symptoms. J Clin Invest 79:777-781, 1987
29. Boyle PJ, Schwartz NS, Clutter WE, Cryer PE: Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and nondiabetics. N Engl J Med 318:1487-1492, 1988
30. Hilsted J, Christensen NJ, Larsen S: Effect of catecholamines and insulin on plasma and intravascular mass of in albumin in man. Clin Sci 77:149-155, 1989
31. Rowe JW, Young JB, Minaker KL, Stevens AL, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219-255, 1981
32. Berne C, Fagius J, Pollare T, Hjemdahl P: The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 35:873-879, 1992
33. O'Hare JA, Minaker KL, Meneilly GS, Rowe JW, Pallotta JA, Young JB. Effect of insulin on plasma norepinephrine and 3,4 dihydrophenylalanine in obese men. Metabolism 38:322-329, 1989
34. Santucci A, Ferri C: Insulin-resistance and essential hypertension: pathophysiological and therapeutical implications. J Hypertens 10 (Suppl. 2):S9-S15, 1992
35. Duly PA, Landsberg L: Hypertension in obesity and NIDDM: role of insulin and sympathetic nervous system. Diabetes Care 14:240-248, 1991
36. The SOLVD Investigators' Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions, N Engl J Med 327:685-691, 1992
37. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H: Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (Consensus II). N Engl J Med 327 678-684, 1992
38. Rouleau JL, Kortas C, Bichet D, De Champlain J: Neurohumoral and haemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms. Am Heart J 116: 746-757, 1988
39. Summer D: Lies damned lies - or statistics? J Hypertens 10.3-8, 1992